Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA panel gives a guarded "yes" to OraSure's 20-minute home HIV test

This article was originally published in Clinica

Executive Summary

After listening to 10 hours of testimony from AIDs activists, private citizens and public health officials, an FDA advisory committee largely endorsed the feasibility of a rapid HIV test that individuals can use in the privacy of their own home. "There's almost unanimous support for this sort of testing," commented Donna DiMichele, acting chairman of the agency's blood products advisory committee, and associate professor of clinical paediatrics at Cornell University Medical School, in New York.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT056898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel